We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksEIH.L Regulatory News (EIH)

  • There is currently no data for EIH

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Net Asset Value(s)

25 Jan 2008 11:05

Evolvence India Holdings PLC25 January 2008 Evolvence India Holdings Announces its Net Asset Value* as at 30 September, 2007 * Company's net assets are US$72.1 million and net asset value per share is US$1.109 Douglas, Isle of Man, 25 January 2008 - Evolvence India Holdings plc ('EIH' or'the Company'), an Isle of Man, private equity fund of funds holding companythat focuses on India, today announced its unaudited net asset value as atSeptember 30, 2007, being its third update since admitting to AIM on 23 March,2007. The Company's net assets, at that date, are valued at US$ 72.1 million and netasset value per share is US$1.109 based on 65 million ordinary shares issuedduring an initial public offering of common stock on AIM, a market of the LondonStock Exchange plc. The NAV per share of US$ 1.109 as at 30 September, 2007represents a growth of 5.3% over the NAV per share of US$ 1.053 as at 30 June,2007. EIH has committed $45.1 million of the net proceeds into Evolvence India Fund('EIF'), an established private equity fund of funds with a co-investment poolfocusing on growth capital in India. The Company has also committed US$6 millionto the Evolvence India Life Sciences Fund, ('EILSF') a private equity fund forinvestments in life sciences businesses in India. The Company has also committedUS$17.7 million in direct investments. The Company's investment objective is to give investors access to a diversifiedIndian private equity portfolio while mitigating issues usually associated withprivate equity investments, such as lack of liquidity and relatively largeminimum investment sizes. Evolvence India Fund closed with US$250 million in commitments. As of 30September, 2007, EIF's portfolio includes investments in eight funds focused onprivate equity, real estate and infrastructure and six co-investments. The totalnumber of portfolio companies (direct, co-investments and underlying fundinvestments) stands at 84 in well diversified growth sectors of the Indianeconomy. The portfolio has had eight successful full exits and five partialexits. Out of the six co-investments, four are already listed and one company(i.e. Emaar MGF Land Limited) is expected to get listed during the first quarterof 2008. "We continue to execute on our strategy of investing in best of breed managersand companies," said Khaled Al Muhairy, Chairman, Evolvence India Holdings. '"With more exits in the pipeline, we believe the portfolio will reflect the truepotential of our investments." EIF's fund portfolio includes investments in eight private equity fundsincluding Baring India Private Equity Fund II, IDFC Private Equity Fund II,India Value Fund II, Leverage India Fund, New York Life Investment ManagementIndia Fund II, Ascent India Fund, JM Financial India Fund and HIREFInternational Fund LLC. The portfolio of six co-investments includesConsolidated Construction Consortium Limited and Zylog Systems Limited, whichgot listed during 2007. India achieved a real GDP growth of 8.9 per cent in the quarter ended 30September, 2007. As per the Centre for Monitoring Indian Economy, the economicgrowth is expected to pick up further in the coming quarters and the year islikely to end with a 9.1 per cent growth in GDP. The expected growth rate forthe quarter ended 30 September, 2007 of 8.9 percent in Indian GDP compares with2.8 percent in the U.S., 3.2 percent in UK, 2.1 percent in Japan, 11.5 percentin China and 5.7 percent in Brazil. "We remain optimistic on the India's robust economic growth and attractiveprivate equity market. EIH is well positioned to further grow its asset class.We look forward to delivering on the strategy we set out at flotation to createsustainable value for our shareholders. Given the continued robustmacro-economic environment in India and the potential of current investments,the future looks promising," added Al Muhairy. Results of EIH Operations: Amount raised in IPO $ 65.0 millionNet proceeds $ 60.0 millionCommitted to Evolvence India Fund $ 45.1 millionCommitted to Evolvence India Life Sciences Fund $ 6.0 millionCapital Committed to direct investments $ 17.7 million Unaudited Valuation as of 30-9-2007 * NAV $72.1 million * NAV per unit $1.109 -Ends - About Evolvence India Holding (EIH): EIH is an Isle of Man incorporated, private equity fund of funds holding companyfocused on India. EIH is promoted by Evolvence Capital Ltd, a Dubai basedalternative investment firm, EIH invests in India through Evolvence India Fundand Evolvence India Life Sciences Fund and the fund managers' network ofrelationships. Contacts: Evolvence India Holdings plcKhaled Al Muhairy, Chairman + (971) 4 315 8100 Evolvence CapitalShilpa Mathai, Communications Manager + (971) 4 315 8100 shilpa@evolvence.com Evolvence Advisory Services Private LimitedParesh Thakker + (91) 98 1849 9990 Fairfax I.S Plc (Broker)Jonathan Brown + (44) 20 7460 4385 Seymour Pierce (Nominated Adviser)Jonathan Wright, Director, Corporate Finance + (44) 20 7107 8000 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
7th May 202011:49 amRNSResult of EGM and Notice of Cancellation
7th Apr 20207:00 amRNSProposed AIM Cancellation and Notice of EGM
2nd Apr 20205:38 pmRNSReturn of Capital and COVID-19 Update
6th Dec 20197:00 amRNSReturn of Capital
29th Nov 20197:00 amRNSDelisting Update
21st Nov 20197:00 amRNSMarket Update
30th Sep 20194:30 pmRNSInterim Results
30th Jul 201911:15 amRNSResult of AGM
28th Jun 20197:00 amRNSPosting of 2018 Annual Results and Notice of AGM
24th May 20195:53 pmRNSHolding(s) in Company
1st May 20197:00 amRNSReturn of Capital
4th Apr 20195:00 pmRNSSale of RSB and Return of Capital
25th Jan 20197:00 amRNSHolding(s) in Company
21st Jan 20196:13 pmRNSHolding(s) in Company
18th Jan 201911:37 amRNSHolding(s) in Company
28th Sep 20187:00 amRNSInterim Results
26th Jul 201811:05 amRNSResult of AGM
28th Jun 20187:00 amRNSPosting of 2017 Annual Report and Notice of AGM
28th Jun 20187:00 amRNSReturn of Capital
20th Mar 20181:00 pmRNSReplacement: Return of Capital
20th Mar 20187:00 amRNSReturn of Capital
29th Sep 20175:17 pmRNSHalf-year Report
29th Sep 20175:13 pmRNSReturn of capital
24th Jul 201710:54 amRNSResults of Annual General Meeting
26th Jun 20176:01 pmRNSDirectorate Change
26th Jun 20176:00 pmRNSPosting of 2016 Annual Report and Notice of AGM
9th Feb 20178:05 amRNSReturn of Capital
26th Jan 20175:08 pmRNSHolding(s) in Company
25th Jan 20179:30 amRNSHolding(s) in Company
5th Jan 20177:00 amRNSUpdate re EIF
30th Sep 20167:00 amRNSHalf-year Report
25th Jul 20161:24 pmRNSResult of AGM
27th Jun 20165:37 pmRNSPosting of Annual Report & Notice of AGM
27th Jun 20167:00 amRNSFinal Results
27th Jun 20167:00 amRNSReturn of Capital
30th Nov 20155:57 pmRNSHolding(s) in Company
30th Sep 20157:00 amRNSInterim Results
30th Jun 201511:53 amRNSResult of AGM
9th Jun 20154:00 pmRNSNotice of AGM
5th Jun 20154:35 pmRNSFinal Results
30th Sep 20147:00 amRNSHalf Yearly Report
14th Jul 20143:19 pmRNSReturn of Capital
30th Jun 201411:57 amRNSResult of AGM
4th Jun 20147:00 amRNSNotice of AGM
3rd Jun 20147:00 amRNSFinal Results
3rd Dec 201311:16 amRNSHolding(s) in Company
2nd Dec 20134:09 pmRNSHolding(s) in Company
28th Nov 20135:14 pmRNSHolding(s) in Company
27th Nov 20133:14 pmRNSSale of Interest in Gland Pharma Limited
22nd Nov 20139:15 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.